Retracted: Parthenolide Inhibits the Proliferation of MDA-T32 Papillary Thyroid Carcinoma Cells In Vitro and in Mouse Tumor Xenografts and Activates Autophagy and Apoptosis by Downregulation of the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Signaling Pathway

Chao Li; Yuqiu Zhou; Yongcong Cai; Chunyan Shui; Wei Liu; Xu Wang; Jian Jiang; Dingfen Zeng; Chunhan Gui; Ronghao Sun

doi:10.12659/MSM.931025

Retracted: Parthenolide Inhibits the Proliferation of MDA-T32 Papillary Thyroid Carcinoma Cells In Vitro and in Mouse Tumor Xenografts and Activates Autophagy and Apoptosis by Downregulation of the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Signaling Pathway

Med Sci Monit. 2021 Mar 11:27:e931025. doi: 10.12659/MSM.931025.

Authors

Chao Li¹, Yuqiu Zhou¹, Yongcong Cai¹, Chunyan Shui², Wei Liu², Xu Wang³, Jian Jiang¹, Dingfen Zeng¹, Chunhan Gui¹, Ronghao Sun¹

Affiliations

¹ Department of Head and Neck Surgery, Sichuan Provincial Cancer Hospital, Chengdu, Sichuan, China (mainland).
² Department of Otolaryngology - Head and Neck Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China (mainland).
³ Graduate School, Chengdu Medical College, Chengdu, Sichuan, China (mainland).

Abstract

This paper is being retracted at the author's request. Reference: 1. Chao Li, Yuqiu Zhou, Yongcong Cai, Chunyan Shui, Wei Liu, Xu Wang, Jian Jiang, Dingfen Zeng, Chunhan Gui, Ronghao Sun: Parthenolide Inhibits the Proliferation of MDA-T32 Papillary Thyroid Carcinoma Cells In Vitro and in Mouse Tumor Xenografts and Activates Autophagy and Apoptosis by Downregulation of the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Signaling Pathway. Med Sci Monit, 2019; 25: 5054-5061. DOI: 10.12659/MSM.915387.

Publication types

Retraction of Publication